351 related articles for article (PubMed ID: 16543784)
41. Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage.
Al-Mufti F; Amuluru K; Damodara N; El-Ghanem M; Nuoman R; Kamal N; Al-Marsoummi S; Morris NA; Dangayach NS; Mayer SA
J Neurol Sci; 2018 Jul; 390():44-51. PubMed ID: 29801906
[TBL] [Abstract][Full Text] [Related]
42. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage.
Raabe A; Beck J; Keller M; Vatter H; Zimmermann M; Seifert V
J Neurosurg; 2005 Dec; 103(6):974-81. PubMed ID: 16381183
[TBL] [Abstract][Full Text] [Related]
43. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
Welty TE
Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
[TBL] [Abstract][Full Text] [Related]
44. [Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Therapeutic value of treatment with calcium antagonists, hypervolemic hemodilution and induced arterial hypertension].
Hansen D; Hannemann L; Specht M; Schaffartzik W
Anaesthesist; 1995 Apr; 44(4):219-29. PubMed ID: 7785750
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
Dorsch NW
Curr Opin Crit Care; 2002 Apr; 8(2):128-33. PubMed ID: 12386513
[TBL] [Abstract][Full Text] [Related]
46. Transcranial Doppler ultrasonography in intensive care.
Rasulo FA; De Peri E; Lavinio A
Eur J Anaesthesiol Suppl; 2008; 42():167-73. PubMed ID: 18289437
[TBL] [Abstract][Full Text] [Related]
47. Cerebral vasospasm after subarachnoid hemorrhage.
Janjua N; Mayer SA
Curr Opin Crit Care; 2003 Apr; 9(2):113-9. PubMed ID: 12657973
[TBL] [Abstract][Full Text] [Related]
48. Medical management of cerebral vasospasm: present and future.
Zubkov AY; Rabinstein AA
Neurol Res; 2009 Jul; 31(6):626-31. PubMed ID: 19055879
[TBL] [Abstract][Full Text] [Related]
49. The challenge of blood pressure management in neurologic emergencies.
Talbert RL
Pharmacotherapy; 2006 Aug; 26(8 Pt 2):123S-130S. PubMed ID: 16863478
[TBL] [Abstract][Full Text] [Related]
50. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
[TBL] [Abstract][Full Text] [Related]
51. [Effect of infusion therapy on central hemodynamics and the outcome of treatment in patients with subarachnoidal hemorrhages].
Shatalov VI; Shchegolev AV
Anesteziol Reanimatol; 2005; (4):55-8. PubMed ID: 16206589
[TBL] [Abstract][Full Text] [Related]
52. Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Trimble JL; Kockler DR
Ann Pharmacother; 2007 Dec; 41(12):2019-23. PubMed ID: 17986515
[TBL] [Abstract][Full Text] [Related]
53. Calcium channel blockers and stroke.
Inzitari D; Poggesi A
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
[TBL] [Abstract][Full Text] [Related]
54. [Vasospasm treatment in intensive care].
Bracco D; Chioléro R
Rev Med Suisse Romande; 2000 Apr; 120(4):355-62. PubMed ID: 10859975
[TBL] [Abstract][Full Text] [Related]
55. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
[TBL] [Abstract][Full Text] [Related]
56. The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective.
Chittiboina P; Conrad S; McCarthy P; Nanda A; Guthikonda B
World Neurosurg; 2011; 75(5-6):660-4. PubMed ID: 21704933
[TBL] [Abstract][Full Text] [Related]
57. A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Li K; Barras CD; Chandra RV; Kok HK; Maingard JT; Carter NS; Russell JH; Lai L; Brooks M; Asadi H
World Neurosurg; 2019 Jun; 126():513-527. PubMed ID: 30898740
[TBL] [Abstract][Full Text] [Related]
58. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
[TBL] [Abstract][Full Text] [Related]
59. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, May, 2003.
Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
J Neurosurg; 2004 Feb; 100(2):359-60; author reply 360. PubMed ID: 15086250
[No Abstract] [Full Text] [Related]
60. The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage.
Dorsch NW
Neurol Med Chir (Tokyo); 1998; 38 Suppl():156-60. PubMed ID: 10234999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
